Related Experiment Videos
Clinical use of systemic IL-12 therapy
J A Gollob1, J W Mier, M B Atkins
1Beth Israel Deaconess Medical Center, Department of Hematology/Oncology, Harvard Medical School, Kirstein Building, Room KS-158, 330 Brookline Avenue, Boston, MA 02215, USA.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
The Proposed U.S. Office of Management and Budget Uniform Guidance Revisions: Implications for Scientific Integrity and HIV Research.
The Journal of the Association of Nurses in AIDS Care : JANAC·2026
Deterministic Economic Modelling Study of Tafamidis in Transthyretin Amyloid Cardiomyopathy Across Four European Healthcare Systems.
European heart journal. Quality of care & clinical outcomes·2026